|
|
Novo Nordisk A/S CDR
TSX •
Healthcare •
Drug Manufacturers - General •
Quote as of 10/30/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeTSX
Market Capitalization74,429 mln
Float3,166 mln
Earnings Date11/04/2026
Relative Strength
89
/ 100
Strongly outperforming
Key Fundamentals
EPS1.76
P/E9.85
ROE60.88
ROIC21.47
ROA21.63
Interest Cover29.90
EBITDA, mln35,728
EV / EBITDA7.18
EV / EBIT8.14
Revenue, mln70,946
EV / Revenue3.80
Quote Details
Last
17.34
Change
0.29 (1.7%)
Open
17.37
Volume
14,943
Turnover
259,112
Average Volume
12,417
Financial Ratios
Pre-Tax Profit Margin45
Leverage Ratio2.69
Current Ratio0.87
Price / Book5.18
Price / Tangible Book11.40
Price / Cash Flow8.53
Price / Free Cash Flow15.46
Debt / Equity0.63
Price / Sales3.50
PEG Ratio0.39
Financial Strength
Altman Z-Score3.72
Piotroski F-Score
5
/ 9
Beneish M-Score-2.33
Price to Intrinsic Value1.23
Price to Lynch Fair Value0.44
Price to Graham Number2.36
Shiller PE Ratio17.14
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
2.24% |
88
/ 100
 |
| 1 Month |
6.25% |
87
/ 100
|
| 2 Months |
-15.16% |
10
/ 100
 |
| 6 Months |
-0.05% |
40
/ 100
 |
|
| |
